Welcome to our dedicated page for MDJM SEC filings (Ticker: UOKA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking both real estate commission income and cultural-venue renovations inside one report can feel like piecing together two separate companies. MDJM LTD (UOKA) often files dense disclosures detailing property developer contracts, historical site acquisitions, and e-commerce rollouts all in one document. If you have ever asked, “How do I find MDJM LTD’s quarterly earnings report 10-Q filing?” or searched for “MDJM LTD insider trading Form 4 transactions,” you already know the challenge: critical numbers are scattered across hundreds of pages and multiple form types.
Stock Titan solves that problem. Our AI parses every submission—10-K, 10-Q, 8-K, Form 4, and the proxy—seconds after it reaches EDGAR. The platform highlights exactly where MDJM LTD breaks out agency commission revenue, lists capital expenditures for its UK heritage hotels, and explains material events in plain English. Need real-time alerts on “MDJM LTD Form 4 insider transactions”? They arrive instantly, complete with AI-generated context so you can gauge whether executives are buying stock ahead of a new cultural venue launch. Our summaries turn complex accounting notes into straightforward insights, making “understanding MDJM LTD SEC documents with AI” a reality.
Investors use these filings to answer practical questions:
- Compare revenue trends between real estate services and cultural asset management in the annual report 10-K simplified.
- Spot segment margins quarter-over-quarter inside the MDJM LTD earnings report filing analysis.
- Monitor executive stock transactions Form 4 before material 8-K announcements, now explained.
- Review the proxy statement executive compensation linked to cultural project milestones.
MDJM LTD reports that Nasdaq has placed the company under a one-year Discretionary Panel Monitor starting from the letter dated November 19, 2025. This step follows Nasdaq’s prior confirmation that MDJM had maintained compliance with its listing rules through October 20, 2025, as required by a June 10, 2025 decision of a Nasdaq Hearings Panel.
During this one-year monitoring period, if MDJM fails to meet any continued listing requirement, Nasdaq’s Listing Qualifications Staff will issue a Delist Determination Letter. In that situation, MDJM would not be allowed to submit a new compliance plan, and the Staff would not be able to grant additional time for the company to regain compliance. This makes any future rule violation more likely to result directly in delisting.
MDJM LTD reported a board change. On November 2, 2025, Yuan Gong resigned as a director for personal reasons, with no disagreement cited; the resignation took effect on November 4, 2025. To fill the vacancy, the Board appointed Bo Wang as a director, effective November 4, 2025, after a recommendation by the Nominating and Corporate Governance Committee. The Board determined Mr. Wang is an independent director. He brings over 20 years of experience in educational services, including founding Spark Learning Limited in 2013 and prior roles with UK and Hong Kong education organizations.
MDJM LTD reports that Nasdaq has allowed the company to maintain its listing. On October 29, 2025, the company received a letter from Nasdaq confirming it had maintained compliance with Nasdaq Listing Rules through October 20, 2025, as required by a June 10, 2025 decision of the Nasdaq Hearings Panel. The Panel therefore determined the company may continue trading on The Nasdaq Stock Market.
MDJM LTD reported the results of its extraordinary general meeting held on October 20, 2025. Shareholders approved an increase of the Company’s authorized share capital.
Participation was high, with 20,465,953 votes present, representing 97.18% of votes exercisable as of the September 25, 2025 record date. The resolution passed with 20,459,854 votes for, 6,079 against, and 20 abstentions.
Authorized share capital sets the maximum number of shares the Company may issue in the future. Approval of this increase provides the corporate authorization needed should the Company choose to issue additional shares under applicable governance and law.